Cipla Uncorks Peptide Injectables Pipeline

Indian Giant Also Eyes Partnering Opportunities For Monkeypox

 
• By Anju Ghangurde

Cipla readies scale-up in peptide injectables with five filings in the US and gears for upcoming high-value launches for generic versions of Advair, Revlimid and Abraxane. The company is also exploring partnering opportunities for monkeypox.

Cipla Outlines Peptide Pipeline Plans • Source: Shutterstock

More from Strategy

More from Business